News
UK moves ahead with GP patient data sharing plan
The UK government has asked the NHS to start putting together the platforms to allow anonymised primary care patient data to be used by researchers.
News
Kailera, Hengrui stake claim to oral weight loss category
Chasing Novo Nordisk and Eli Lilly, Kailera and Hengrui have reported 12.1% weight loss in phase 2 with their oral GIP/GLP-1 agonist ribupatide.
News
Takeda signs $1.7bn AI alliance with Iambic
Iambic bags another pharma partner, Takeda, which plans to use its AI platform to find drugs for cancer, gastrointestinal, and inflammatory disorders.
R&D
AMR and vaccines: Can universal coverage avert a post-antibi...
Antimicrobial resistance (AMR) is a growing global health crisis.
R&D
Treating the chronic diseases GLP-1s miss, with Laurent Auda...
Prive Bio CEO Laurent Audaly spoke with pharmaphorum during the JP Morgan Healthcare conference, discussing GLP-1s in the cardiometabolic space.
Debates & Insights
News
Press Releases
Editor's Picks
Editor's Picks
